Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003030774 | SCV003310518 | uncertain significance | Congenital brain dysgenesis due to glutamine synthetase deficiency | 2022-05-12 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This premature translational stop signal has been observed in individual(s) with GLUL-related conditions (PMID: 33150193). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg106*) in the GLUL gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in GLUL cause disease. |